March 19, 2026—iVascular announced 1-year results from the BARISTA clinical trial, which is evaluating the safety and efficacy of the company&rs ...
March 18, 2026—iVascular announced 3-year follow-up results from the LUMIFOLLOW registry, a large real-world study evaluating the safety and eff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results